Loading...
Loading...
Of the 3 tracked institutions holding GRCE, 2 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +8.4pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 3 tracked institutional investors we monitor, GRCE (GRACE THERAPEUTICS INC) is held with a combined value of $3.07M across 766,633 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.48M. 3 funds increased their holdings.
Total Institutional Value
$3.07M
Total Shares Held
766,633
Institutional Holders
3
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.48M | 0.00% | +3.6% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $1.13M | 0.00% | +87.9% |
| 3 | CITADEL ADVISORS LLC | $457.18K | 0.00% | +133.4% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of GRCE with a position worth $1.48M, representing 0.00% of their portfolio. In total, 3 institutional investors hold GRCE with a combined value of $3.07M.
Institutional investors hold $3.07M worth of GRCE stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $1.48M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GRCE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GRCE positions.
Last Close
$2.33
2026-07-24
YTD
-36.3%
8% of 52-week range
